Thursday, September 15, 2022
HomeBiotechnologyNew patent for Azurity drug EPRONTIA – DrugPatentWatch

New patent for Azurity drug EPRONTIA – DrugPatentWatch


Copyright © DrugPatentWatch. Initially revealed at New patent for Azurity drug EPRONTIA

Annual Drug Patent Expirations for EPRONTIA
Annual Drug Patent Expirations for EPRONTIA

Eprontia is a drug marketed by Azurity and is included in a single NDA. It’s accessible from one provider.

The generic ingredient in EPRONTIA is topiramate. One provider is listed for this compound. Further particulars can be found on the topiramate profile web page.

For extra data on how DrugPatentWatch may also help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com

Make Higher Choices with DrugPatentWatch

» Begin Your Free Trial Right now «

Copyright © DrugPatentWatch. Initially revealed at New patent for Azurity drug EPRONTIA

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments